Serum trypsinogen-2 and trypsin-2-α1-antitrypsin complex in malignant and benign digestive-tract diseases. Preferential elevation in patients with cholangiocarcinomas

International Journal of Cancer

Volumn 66, Issue 3, 1996, Pages 326-331

  Hedström, Johan ^a   Haglund, Caj ^a   Haapiainen, Reijo ^a   Stenman, Ulf Håkan ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; TRYPSINOGEN;

ARTICLE; BILE DUCT CARCINOMA; BLOOD LEVEL; CONTROLLED STUDY; DIGESTIVE SYSTEM DISEASE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ALPHA 1-ANTITRYPSIN; AMYLASES; BILE DUCT NEOPLASMS; BILIRUBIN; BIOLOGICAL MARKERS; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; DIGESTIVE SYSTEM DISEASES; DIGESTIVE SYSTEM NEOPLASMS; FALSE POSITIVE REACTIONS; HUMANS; LIVER NEOPLASMS; PANCREATIC NEOPLASMS; TRYPSIN; TRYPSINOGEN; TUMOR MARKERS, BIOLOGICAL;

EID: 0029931308     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960503)66:3<326::AID-IJC10>3.0.CO;2-9     Document Type: Article

References (24)

1. BORGSTRÖM, A. and OHLSSON, K., Studies on the turnover of endogenous cathodal trypsinogen in man. Europ. J. clin Invest , 8, 379-382 (1978).
2. COLLAZOS, J., GENOLLA, J. and RUIBAL, A., Serum levels of CA 50 in nonmalignant liver diseases: a clinical and biochemical study. Amer. J. Gastroenterol., 88, 409-412 (1993).
3. CROSSLEY, J.R., ELLIOTT, R.B. and SMITH, P.A., Dried-blood spot screening for cystic fibrosis in the newborn. Lancet. I, 472-474 (1979).
4. ELIAS, E., REDSHAW, M. and WOOD, T., Diagnostic importance of changes in circulating concentrations of immunoreactive trypsin. Lancet, II, 66-68 (1977).
5. FABRIS, C., BASSO, D., DEL-FAVERO, G., MEGGIATO, T., PICCOLI, A., ANGONESE, C., PLEBANI, M., BONVICINI, P., BRULINA, A. and NACCARATO, R., Renal handling of amylase and immunoreactive trypsin in pancreatic cancer and chronic pancreatitis. Clin. physiol. Biochem., 8, 30-37 (1990).
6. HAGLUND, C., ROBERTS, P.J , KUUSELA, P., SCHEININ, T.M., MAKELA, O. and JALANKO, H., Evaluation of CA 19-9 as a serum tumour marker in pancreatic cancer. Brit. J. Cancer, 53, 197-202 (1986).
7. 1-antitrypsin in serum. Clin. Chem., 40, 1761-1765 (1994).
8. ITKONEN, O., KOIVUNEN, E., HURME, M., ALFTHAN, H., SCHRÖDER, T. and STENMAN, U.-H., Time-resolved immunofluorometric assays for trypsinogen-1 and 2 in serum reveal preferential elevation of trypsinogen-2 in pancreatitis. J. Lab. clin. Med., 115, 712-718 (1990).
9. KOIVUNEN, E., HUHTALA, M.-L. and STENMAN, U.-H., Human ovarian tumor-associated trypsin. Its purification and characterization from mucinous cyst fluid and identification as an activator of prourokinase. J. biol. Chem., 264, 14095-14099 (1989).
10. KOIVUNEN, E., ITKONEN, O., HALILA, H. and STENMAN, U.-H., Cyst fluid of ovarian cancer patients contains high concentrations of trypsinogen-2. Cancer Res., 50, 2375-2378 (1990).
11. KOIVUNEN, E., RISTIMAKI, A., ITKONEN, O., OSMAN, S., VUENTO, M. and STENMAN, U.-H., Tumor-associated trypsin participates in cancer cell-mediated degradation of extracellular matrix. Cancer Res., 51, 2107-2112 (1991).
12. LAKE-BAKAAR, G., MCKAVANAGH, S. and SUMMERFIELD, J.A., Urinary immunoreactive trypsin excretion: a non-invasive screening test for pancreatic cancer. Lancet, II, 878-880 (1979).
13. MALLORY, P.A. and TRAVIS, J., Human pancreatic enzymes: characterization of anionic human trypsin. Biochemistry, 12, 2847-2851 (1973).
14. MISZCZUK-JAMSKA, B., MERTEN, M., GUY-CROTTE, O., AMOURIC, M., CLEMENTE, F., SCHOUMACHER, R.A. and FIGARELLA, C., Characterization of trypsinogens 1 and 2 in two human pancreatic adenocancer cell lines: CFPAC-1 and CAPAN-1. FEBS Lett., 294, 175-178 (1991).
15. MOLLER-PETERSEN, J. and SMIDT-JENSEN, S., The use and mechanism of urinary clearance of cathodic trypsin-like immunoreactivity to creatinine clearance ratio in the diagnosis of pancreatic cancer. Clin. chim. Acta, 130, 163-170 (1983).
16. OHLSSON, K., Acute pancreatitis. Biochemical, pathophysiological and therapeutical aspects. Acta gastroenterol. belg., 51, 3-12 (1988).
17. OHLSSON, K. and EDDELAND, A., Release of proteolytic enzymes in bile-induced pancreatitis in dogs. Gastroenterology, 69, 668-675 (1975).
18. OHTA, T., TERADA, T., NAGAKAWA, T., TAJIMA, T., ITOH, H., FONSECA, L. and MIYAZAKI, I., Pancreatic trypsinogen and cathepsin B in human pancreatic cancers and associated metastatic lesions. Brit. J. Cancer, 69, 152-156 (1994).
19. ROBINSON, L.A., KIM, W.J., WHITE, T.T. and HADORN, B., Trypsins in human pancreatic juice - their distribution as found in 34 specimens. Scand. J. Gastroenterol., 7, 43-45 (1972).
20. STEINBERG, W.M., GOLDSTEIN, S.S., DAVIS, N.D., SHAMMA'A, J. and ANDERSON, K., Diagnostic assays in acute pancreatitis. A study of sensitivity and specificity. Ann. intern. Med., 102, 576-580 (1985).
21. TERADA, T., KIDA, T. and NAKANUMA, Y., Extrahepatic peribiliary glands express α-amylase isozymes, trypsin and pancreatic lipase: an immunohistochemical analysis. Hepatology, 18, 803-808 (1993).
22. TERADA, T. and NAKANUMA, Y., Immunohistochemical demonstration of pancreatic α-amylase and trypsin in intrahepatic bile ducts and peribiliary glands. Hepatology, 14, 1129-1135 (1991).
23. TERADA, T., OHTA, T., MINATO, H. and NAKANUMA, Y., Expression of pancreatic trypsinogen/trypsin and cathepsin B in human cholangio-cancers and hepatocellular cancers. Human Pathol. 26, 746-752 (1995).
24. ZWEIG, M.H. and CAMPBELL, G., Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine (Review). Clin. Chem., 39, 561-577 (1993).